GS
Graig Suvannavejh Mizuho Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
41
Avg Return
Past Year
Past Year
35%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
81.3%
Neutral
18.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $205 |
106%
upside
| 1 | +10% |
0
%
| 7 Jan ‘26 10 days ago |
|
|
|
Outperform
Maintained
| $5 |
48%
downside
| 1 | +188% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $54 |
48%
upside
| 3 | +45% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Outperform
Upgraded
| $194 |
25%
upside
| 2 | +0.71% |
0
%
| 2 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $256 |
59%
upside
| 1 | +24% |
0
%
| 1 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $46 |
27%
upside
| 2 | +1.2% |
0
%
| 1 Dec ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $100 |
41%
upside
| 1 | -7.7% |
0
%
| 20 Nov ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $23 |
134%
upside
| 1 | -4.7% |
0
%
| 19 Nov ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $56 |
21%
downside
| 1 | – |
–
| 18 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $46 |
28%
upside
| 1 | +20% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $202 |
14%
upside
| 1 | +12% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $19 |
5%
downside
| 1 | – |
–
| 3 Nov ‘25 2 months ago |
|